Brian Ko, M.D.
Medical Officer
Investigational Drug Branch
NCI DCTD Cancer Therapy Evaluation Program
Dr. Brian Ko joined the Investigational Drug Branch (IDB) at the National Cancer Institute (NCI) in 2024. He earned his undergraduate degree from Harvard University and his M.D. from the University of Illinois. He completed his internal medicine residency and medical oncology/hematology fellowship at Montefiore Einstein, followed by further subspeciality training in early phase cancer clinical trials and oncologic drug development at the Advanced Developmental Therapeutics Training Program at NCI.